Research Papers:

O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes

Minjun Kim, Yoon Sook Kim, Hwajin Kim, Min Young Kang, Jeongsook Park, Dong Hoon Lee, Gu Seob Roh, Hyun Joon Kim, Sang Soo Kang, Gyeong Jae Cho, Ji Kwon Park, Jin Won Cho, Jeong Kyu Shin and Wan Sung Choi _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:44596-44607. https://doi.org/10.18632/oncotarget.10112

Metrics: PDF 2502 views  |   HTML 2828 views  |   ?  


Minjun Kim1,*, Yoon Sook Kim1,*, Hwajin Kim1,*, Min Young Kang2, Jeongsook Park1, Dong Hoon Lee1, Gu Seob Roh1, Hyun Joon Kim1, Sang Soo Kang1, Gyeong Jae Cho1, Ji Kwon Park2, Jin Won Cho3, Jeong Kyu Shin2, Wan Sung Choi1

1Department of Anatomy and Convergence Medical Science, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju, Gyeongnam, Republic of Korea

2Department of Obstetrics and Gynecology, Gyeongsang National University School of Medicine, Jinju, Gyeongnam, Republic of Korea

3Department of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University, Seoul, Republic of Korea

*These authors have contributed equally to this work

Correspondence to:

Wan Sung Choi, email: [email protected]

Jeong Kyu Shin, email: [email protected]

Keywords: O-GlcNAcylation, host cell factor 1, OGT, E6 and E7

Received: December 18, 2015    Accepted: June 01, 2016    Published: June 16, 2016


O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) increases O-GlcNAc modification (O-GlcNAcylation), and transcriptional co-regulator host cell factor 1 (HCF-1) is one of OGT targets. High-risk Human Papillomaviruses (HPVs) encode E6 and E7 oncoproteins, which promote cervical cancer. Here, we tested whether O-GlcNAc modification of HCF-1 affects HPV E6 and E7 expressions and tumorigenesis of cervical cancer. We found that depleting OGT with OGT-specific shRNA significantly decreased levels of E6 and E7 oncoproteins, and cervical cancer tumorigenesis, while OGT overexpression greatly increased levels of E6 and E7 oncoproteins. Notably, OGT overexpression caused dose-dependent increases in the transcriptional activity of E6 and E7, and this activity was decreased when HCF-1 was depleted with HCF-1-specific siRNA. Moreover, OGT depletion reduced proliferation, invasion, and metastasis in cervical cancer cells. Further, high glucose enhanced the interaction between OGT and HCF-1, paralleling increased levels of E6 and E7 in cervical cancer cells. Most importantly, we found that reducing OGT in HeLa cells caused decreased tumor growth in vivo. These findings identify OGT as a novel cellular factor involved in E6 and E7 expressions and cervical cancer tumorigenesis, suggesting that targeting OGT in cervical cancer may have potential therapeutic benefit.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10112